The largest database of trusted experimental protocols

4 protocols using human igg1

1

Humanized Mouse Model for GVHD

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neonatal foreskins were grafted onto the backs of 6- to 8-week old nonobese diabetic /severe combined immunodeficient/IL-2 receptor γ chain null mice (NSG, Jackson Laboratory, Bar Harbor, ME). One week later, 3 × 106 allogeneic PBMCs, TCM, TMM or TEM were injected intravenously. In indicated experiments, alemtuzumab (2.5 μg) or isotype control (human IgG1, BioLegend) was injected i.p. three times per week for 3 weeks. Three weeks after cell injection, blood, spleen and skin grafts were harvested for analysis. All experiments were approved by the Brigham and Women’s Hospital Institutional Animal Care and Use Committee (IACUC protocol # 2016N000591).
+ Open protocol
+ Expand
2

Humanized Mouse Model of Skin Graft Rejection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neonatal foreskins were grafted onto the backs of 6- to 8-week-old NOD/SCID/IL-2 receptor γ chainnull mice (Jackson Laboratories). One week later 5 x 106 allogeneic PBMC were injected i.v. after isolation from healthy donors by ficoll centrifugation. Antibody injections commenced 2–4 weeks after PBMC engraftment. Alemtuzumab (2.5 μg) or isotype control (human IgG1, Biolegend) was injected i.p. 3 times/week for 3 weeks. Anti-CD3-diphtheria toxin (A-dmDT(390)-bisFv(UCHT1), 0.625 μg) or isotype control (human IgG1) was injected i.v. once/day for 4 days. At the conclusion of the experiment, blood and skin grafts were harvested for analysis by flow cytometry, immunofluorescence and/or hematoxylin/eosin staining.
+ Open protocol
+ Expand
3

In vitro Immune Checkpoint Inhibitor Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture medium α-Modified Essential Medium+GlutaMAX (α-MEM), L-glutamine, and fetal bovine serum (FBS) were purchased from Gibco, Life Technologies Limited, UK. Dulbecco phosphate-buffered saline and media supplements (including penicillin/streptomycin, β-glycerol phosphate, ascorbic acid, and dexamethasone) were purchased from Sigma Aldrich, USA. The cytokines human macrophage colony-stimulating factor (M-CSF) and human receptor activator of nuclear factor kappa B ligand (RANKL) were obtained from Peprotech, UK. The PD1i pembrolizumab and the PD-L1i atezolizumab were purchased from Selleck Chemicals, TX, USA; as an antibody control, we used the human IgG1 from Biolegend, San Diego, CA, USA (cat. number 403501). In line with most in vitro studies,10 11 (link) experiments were performed with ICI concentrations of 0.05–1 µg/mL, which reflect the poor biodistribution of ICIs in the bone.12–14 (link)
+ Open protocol
+ Expand
4

Murine and Humanized PMN310 Antibody Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine PMN310 (muPMN310) monoclonal antibody used in the studies presented was either purified from hybridoma supernatant by ImmunoPrecise Antibodies or produced by WuXi Biologics (Hong Kong, China) by transient transfection of Chinese hamster ovary (CHO) cells with a vector encoding the hybridoma variable regions cloned into a murine IgG1 framework. Humanized PMN310 (huPMN310) was generated by Abzena (Cambridge, UK) by cloning the humanized variable region genes of muPMN310 into vectors encoding a human IgG4 (S241P hinge variant) heavy chain constant domain and a human kappa light chain constant domain. Aducanumab and bapineuzumab were purchased from Creative Biolabs (Upton NY, USA). Negative isotype controls including murine IgG1, human IgG1 and human IgG4 were purchased from BioLegend (San Diego CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!